Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Can PlexusDx help me understand my personal risk for severe side effects
13 NONCLINICAL TOXICOLOGY NONCLINICAL TOXICOLOGY SECTION 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION In a 2-year carcinogenicity study in CD-1 mice, subcutaneous doses of 0.3, 1 and 3 mg/kg/day (2-, 8-, and 22-fold the maximum recommended human dose [MRHD] of 2.4 mg/week, based on AUC) were administered to the males, and 0.1, 0.3 and 1 mg/kg/day (0.6-, 2-, and 5-fold MRHD) were administered to the females
[3] Katturajan R, Evan Prince S
The gap between those two figures is where most unpleasant surprises live
Week 4 FirstMonth Milestones At this point, progress becomes visible
